Pasithea Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Pasithea Therapeutics has a total shareholder equity of $17.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.6M and $824.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.36m |
| Equity | US$17.81m |
| Total liabilities | US$823.98k |
| Total assets | US$18.64m |
Financial Position Analysis
Short Term Liabilities: KTTA's short term assets ($9.8M) exceed its short term liabilities ($660.4K).
Long Term Liabilities: KTTA's short term assets ($9.8M) exceed its long term liabilities ($163.6K).
Debt to Equity History and Analysis
Debt Level: KTTA is debt free.
Reducing Debt: KTTA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KTTA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: KTTA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.3% each year